237 related articles for article (PubMed ID: 26092470)
1. MRP1 knockdown down-regulates the deposition of collagen and leads to a reduced hypertrophic scar fibrosis.
Li Y; Yang L; Zheng Z; Shi J; Wu X; Guan H; Jia Y; Tao K; Wang H; Han S; Gao J; Zhao B; Su L; Hu D
J Mol Histol; 2015 Oct; 46(4-5):357-64. PubMed ID: 26092470
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1.
Li Y; Zhang J; Zhang W; Liu Y; Li Y; Wang K; Zhang Y; Yang C; Li X; Shi J; Su L; Hu D
J Mol Histol; 2017 Dec; 48(5-6):357-366. PubMed ID: 28884252
[TBL] [Abstract][Full Text] [Related]
3. Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway.
Li Y; Zhang W; Gao J; Liu J; Wang H; Li J; Yang X; He T; Guan H; Zheng Z; Han S; Dong M; Han J; Shi J; Hu D
Stem Cell Res Ther; 2016 Aug; 7(1):102. PubMed ID: 27484727
[TBL] [Abstract][Full Text] [Related]
4. Study on the role of Hsa-miR-31-5p in hypertrophic scar formation and the mechanism.
Wang X; Zhang Y; Jiang BH; Zhang Q; Zhou RP; Zhang L; Wang C
Exp Cell Res; 2017 Dec; 361(2):201-209. PubMed ID: 29056521
[TBL] [Abstract][Full Text] [Related]
5. Cryptotanshinone downregulates the profibrotic activities of hypertrophic scar fibroblasts and accelerates wound healing: A potential therapy for the reduction of skin scarring.
Li Y; Shi S; Gao J; Han S; Wu X; Jia Y; Su L; Shi J; Hu D
Biomed Pharmacother; 2016 May; 80():80-86. PubMed ID: 27133042
[TBL] [Abstract][Full Text] [Related]
6. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
7. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.
Li Y; Zhang J; Shi J; Liu K; Wang X; Jia Y; He T; Shen K; Wang Y; Liu J; Zhang W; Wang H; Zheng Z; Hu D
Stem Cell Res Ther; 2021 Mar; 12(1):221. PubMed ID: 33789737
[TBL] [Abstract][Full Text] [Related]
8. Autophagy protein LC3 regulates the fibrosis of hypertrophic scar by controlling Bcl-xL in dermal fibroblasts.
Shi J; Shi S; Wu B; Zhang J; Li Y; Wu X; Zhang J; Wang K; Zhao B; Cai W; Bai X; Hu D; Guan H
Oncotarget; 2017 Nov; 8(55):93757-93770. PubMed ID: 29212187
[TBL] [Abstract][Full Text] [Related]
9. miR-155 inhibits the formation of hypertrophic scar fibroblasts by targeting HIF-1α via PI3K/AKT pathway.
Wu X; Li J; Yang X; Bai X; Shi J; Gao J; Li Y; Han S; Zhang Y; Han F; Liu Y; Li X; Wang K; Zhang J; Wang Z; Tao K; Hu D
J Mol Histol; 2018 Aug; 49(4):377-387. PubMed ID: 29785488
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous deactivation of FAK and Src improves the pathology of hypertrophic scar.
Su L; Li X; Wu X; Hui B; Han S; Gao J; Li Y; Shi J; Zhu H; Zhao B; Hu D
Sci Rep; 2016 May; 6():26023. PubMed ID: 27181267
[TBL] [Abstract][Full Text] [Related]
11. Smad interacting protein 1 influences transforming growth factor-β
Fang X; Hu X; Zheng Z; Tao K; Wang H; Guan H; Shi J; Ji P; Cai W; Bai X; Zhu X; Han J; Liu J; Hu D
J Mol Histol; 2019 Dec; 50(6):503-514. PubMed ID: 31595443
[TBL] [Abstract][Full Text] [Related]
12. IL-10 alleviates lipopolysaccharide-induced skin scarring via IL-10R/STAT3 axis regulating TLR4/NF-κB pathway in dermal fibroblasts.
Shi J; Shi S; Xie W; Zhao M; Li Y; Zhang J; Li N; Bai X; Cai W; Hu X; Hu D; Han J; Guan H
J Cell Mol Med; 2021 Feb; 25(3):1554-1567. PubMed ID: 33410606
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the association between drug transporter and actin cytoskeleton abolishes drug resistance in hypertrophic scar.
Su L; Fu L; Li Y; Yang F; Zhang M; Hu D
Oncotarget; 2017 Jan; 8(2):2617-2627. PubMed ID: 27926506
[TBL] [Abstract][Full Text] [Related]
14. The use of gene activated matrix to mediate effective SMAD2 gene silencing against hypertrophic scar.
Yin L; Zhao X; Ji S; He C; Wang G; Tang C; Gu S; Yin C
Biomaterials; 2014 Mar; 35(8):2488-98. PubMed ID: 24388384
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of FKBP10 Attenuates Hypertrophic Scarring through Suppressing Fibroblast Activity and Extracellular Matrix Deposition.
Liang X; Chai B; Duan R; Zhou Y; Huang X; Li Q
J Invest Dermatol; 2017 Nov; 137(11):2326-2335. PubMed ID: 28774593
[TBL] [Abstract][Full Text] [Related]
16. [Expression of endosialin in human hypertrophic scars and its regulation on fibroblast phenotype].
Zhang QY; Zhang LX; Han DH; Jiao XC; Zheng Z; Guo K; Yang YS
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Dec; 39(12):1168-1174. PubMed ID: 38129304
[No Abstract] [Full Text] [Related]
17. Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.
Li Y; Yu Z; Zhao D; Han D
Life Sci; 2021 Jul; 277():119483. PubMed ID: 33862115
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of electron transfer flavoprotein β subunit reduced TGF-β-induced α-SMA mRNA expression but not COL1A1 in fibroblast-populated three-dimensional collagen gel cultures.
Hirokawa S; Shimanuki T; Kitajima H; Nishimori Y; Shimosaka M
J Dermatol Sci; 2012 Dec; 68(3):179-86. PubMed ID: 23068445
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway.
Mu S; Kang B; Zeng W; Sun Y; Yang F
Mol Cell Biochem; 2016 May; 416(1-2):99-108. PubMed ID: 27075467
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression signature and the therapeutic effect of the microRNA‑21 antagomir in hypertrophic scarring.
Guo L; Xu K; Yan H; Feng H; Wang T; Chai L; Xu G
Mol Med Rep; 2017 Mar; 15(3):1211-1221. PubMed ID: 28075443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
